About Opto Global
Opto Global is a Healthcare company based in Adelaide (Australia) founded in 2003, and was acquired by Optos in November 2010. Ophthalmic diagnostic and therapeutic devices are provided by Opto Global. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy.
Company details
Opto Global, a subsidiary of Optos, offers a portfolio of ophthalmic diagnostic and treatment devices. The companys products include laser photocoagulators, corneal cross linking systems, laser photocoagulators, surgical microscopes, automated perimeters, eye tracker systems, green laser photocoagulators, and digital visual acuity system. The company also offers Opto AngioCam, a digital angiography system for the retinal specialist that enables to perform fluorescein angiography, indocyanine green angiography, and red free and colour fundus imaging in digital photographs and live-motion video. Opto Global also offers Indocyanine Green-Mediated Photothrombosis a laser-dye modality indicated for the treatment of age-related macular degeneration and other neovascular lesions, such as angioid streaks, pathologic myopia, and conditions from inflammatory and idiopathic diseases. The company serves ophthalmologists, optometrists, aid agencies, hospitals, and associated health care professionals. The company offers its products through a network of distributors in Australia and internationally. Opto Global Pty Ltd. was formerly known as EyeP.
- Headquarters Adelaide, Australia
- Stage Acquired
- SectorsHealthcare
- Website opto-global.com
- Social LinkedIn
- Acquired by Optos (Nov 2010)
- InvestorsPlymouth Growth
& 1 more
- Acquired byOptos
(Nov 2010)
Funding Insights of Opto Global
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Opto Global with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2007 | Private Equity Round | – | – |
2 investors in total: 2 institutional.
Investors in Opto Global
Opto Global has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Plymouth Growth and Optos.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth stage tech & offline focused VC firm funding companies in the US | 2003 | plymouthgp.com | Ann Arbor, United States | |
Ultra-widefield retinal imaging devices are manufactured for eye disease detection. | 1992 | optos.com | Dunfermline, United Kingdom |
Investor details for Opto Global
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Opto Global
3 dated milestones of Opto Global across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Opto Global is founded.
- Funding First funding round.
- Exit Acquired by Optos.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Opto Global
Opto Global was founded in 2003 and raised its 1st funding round 4 years after it was founded.
Opto Global is headquartered in Adelaide, Australia. It is registered at Adelaide, South Australia, Australia.
Opto Global, a subsidiary of Optos, offers a portfolio of ophthalmic diagnostic and treatment devices. The companys products include laser photocoagulators, corneal cross linking systems, laser photocoagulators, surgical microscopes, automated perimeters, eye tracker systems, green laser photocoagulators, and digital visual acuity system. The company also offers Opto AngioCam, a digital angiography system for the retinal specialist that enables to perform fluorescein angiography, indocyanine green angiography, and red free and colour fundus imaging in digital photographs and live-motion video. Opto Global also offers Indocyanine Green-Mediated Photothrombosis a laser-dye modality indicated for the treatment of age-related macular degeneration and other neovascular lesions, such as angioid streaks, pathologic myopia, and conditions from inflammatory and idiopathic diseases. The company serves ophthalmologists, optometrists, aid agencies, hospitals, and associated health care professionals. The company offers its products through a network of distributors in Australia and internationally. Opto Global Pty Ltd. was formerly known as EyeP.
Opto Global has 2 investors. Key investors include Plymouth Growth, and Optos.
Yes. Opto Global was acquired by Optos in November 2010.